{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:22:31Z","timestamp":1785493351713,"version":"3.56.0"},"reference-count":137,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T00:00:00Z","timestamp":1602028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.575572","type":"journal-article","created":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T07:02:36Z","timestamp":1602054156000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["Regulatory T Cells in Autoimmune Hepatitis: Unveiling Their Roles in Mouse Models and Patients"],"prefix":"10.3389","volume":"11","author":[{"given":"Han","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxia","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1038\/s41395-018-0058-z","article-title":"Clinical narrative: autoimmune hepatitis","volume":"113","author":"Schmeltzer","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","article-title":"Autoimmune hepatitis","volume":"4","author":"Mieli-Vergani","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0140-6736(12)62163-1","article-title":"Autoimmune hepatitis","volume":"382","author":"Heneghan","year":"2013","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jhep.2015.03.005","article-title":"Autoimmune hepatitis\u2013update 2015","volume":"62","author":"Manns","year":"2015","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/liv.14062","article-title":"Autoimmune hepatitis: current and future therapeutic options","volume":"39","author":"Doycheva","year":"2019","journal-title":"Liver Int"},{"key":"B7","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/liv.14051","article-title":"Stopping immunosuppressive treatment in autoimmune hepatitis (AIH): is it justified (and in whom and when)?","volume":"39","author":"Harrison","year":"2019","journal-title":"Liver Int"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.3390\/ijms17122007","article-title":"Immunopathogenic mechanisms of autoimmune hepatitis: how much do we know from animal models?","volume":"17","author":"Christen","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.bbadis.2018.05.017","article-title":"Animal models of autoimmune hepatitis","volume":"1865","author":"Christen","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1172\/JCI115836","article-title":"A T cell-dependent experimental liver injury in mice inducible by concanavalin A","volume":"90","author":"Tiegs","year":"1992","journal-title":"J Clin Invest"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1084\/jem.20071859","article-title":"Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection","volume":"205","author":"Holdener","year":"2008","journal-title":"J Exp Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1002\/hep.26380","article-title":"Genetic predisposition and environmental danger signals initiate chronic autoimmune hepatitis driven by CD4+ T cells","volume":"58","author":"Hardtke-Wolenski","year":"2013","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaut.2016.12.001","article-title":"The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease development","volume":"78","author":"Hardtke-Wolenski","year":"2017","journal-title":"J Autoimmun"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12967-019-02180-3","article-title":"Plasma proteomic analysis of autoimmune hepatitis in an improved AIH mouse model","volume":"18","author":"Wang","year":"2020","journal-title":"J Transl Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","article-title":"Human FOXP3(+) regulatory T cell heterogeneity and function in autoimmunity and cancer","volume":"50","author":"Wing","year":"2019","journal-title":"Immunity"},{"key":"B16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.smim.2013.10.009","article-title":"The plasticity of human Treg and Th17 cells and its role in autoimmunity","volume":"25","author":"Kleinewietfeld","year":"2013","journal-title":"Semin Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"7181685","DOI":"10.1155\/2016\/7181685","article-title":"Autoimmune hepatitis: progress from global immunosuppression to personalised regulatory T cell therapy","volume":"2016","author":"Than","year":"2016","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","article-title":"Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis","volume":"176","author":"Longhi","year":"2006","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jhep.2012.02.029","article-title":"FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency","volume":"57","author":"Peiseler","year":"2012","journal-title":"J Hepatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1111\/liv.14480","article-title":"Incidence, prevalence, and mortality of autoimmune hepatitis in England 1997\u20132015. A population-based cohort study","volume":"40","author":"Gronbaek","year":"2020","journal-title":"Liver Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"430","DOI":"10.5009\/gnl19261","article-title":"Autoimmune hepatitis: 2019 update","volume":"14","author":"Tanaka","year":"2020","journal-title":"Gut Liver."},{"key":"B22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3389\/fimmu.2018.00609","article-title":"Autoantibodies in autoimmune liver disease-clinical and diagnostic relevance","volume":"9","author":"Sebode","year":"2018","journal-title":"Front Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1111\/apt.13210","article-title":"Type 1 and type 2 autoimmune hepatitis in adults share the same clinical phenotype","volume":"41","author":"Muratori","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"B24","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/hep.26666","article-title":"Antismooth muscle and antiactin antibodies are indirect markers of histological and biochemical activity of autoimmune hepatitis","volume":"59","author":"Couto","year":"2014","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s12072-013-9448-x","article-title":"Autoimmune hepatitis: the role of environmental risk factors: a population-based study","volume":"7","author":"Ngu","year":"2013","journal-title":"Hepatol Int"},{"key":"B26","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/ajg.2017.456","article-title":"Hospitalizations for autoimmune hepatitis disproportionately affect Black and Latino Americans","volume":"113","author":"Wen","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1016\/j.cgh.2018.11.028","article-title":"Association between black race and presentation and liver-related outcomes of patients with autoimmune hepatitis","volume":"17","author":"de Boer","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s12072-016-9727-4","article-title":"Difference in clinical presentation, immunology profile and treatment response of type 1 autoimmune hepatitis between United Kingdom and Singapore patients","volume":"10","author":"Than","year":"2016","journal-title":"Hepatol Int"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/hep.27991","article-title":"Depletion of B cells induces remission of autoimmune hepatitis in mice through reduced antigen presentation and help to T cells","volume":"62","author":"Beland","year":"2015","journal-title":"Hepatology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1002\/hep.29307","article-title":"Regulatory T-cell conditioning endows activated effector T cells with suppressor function in autoimmune hepatitis\/autoimmune sclerosing cholangitis","volume":"66","author":"Liberal","year":"2017","journal-title":"Hepatology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1038\/s41419-017-0010-y","article-title":"Increased apoptosis of regulatory T cells in patients with active autoimmune hepatitis","volume":"8","author":"John","year":"2017","journal-title":"Cell Death Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/hep.27884","article-title":"In autoimmune hepatitis type 1 or the autoimmune hepatitis-sclerosing cholangitis variant defective regulatory T-cell responsiveness to IL-2 results in low IL-10 production and impaired suppression","volume":"62","author":"Liberal","year":"2015","journal-title":"Hepatology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/hep.29418","article-title":"A functional characteristic of cysteine-rich protein 61: modulation of myeloid-derived suppressor cells in liver inflammation","volume":"67","author":"Zhang","year":"2018","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1038\/s41467-019-09893-5","article-title":"Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines","volume":"10","author":"Umeshappa","year":"2019","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/hep.23042","article-title":"Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease","volume":"50","author":"Yeoman","year":"2009","journal-title":"Hepatology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/apt.15029","article-title":"Severe vitamin D deficiency is a prognostic biomarker in autoimmune hepatitis","volume":"49","author":"Ebadi","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e0198757","DOI":"10.1371\/journal.pone.0198757","article-title":"Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease","volume":"13","author":"Abe","year":"2018","journal-title":"PLoS ONE."},{"key":"B38","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-naive patients","volume":"55","author":"Zachou","year":"2011","journal-title":"J Hepatol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.imlet.2007.02.008","article-title":"Suppression of immune-mediated liver injury after vaccination with attenuated pathogenic cells","volume":"110","author":"Mei","year":"2007","journal-title":"Immunol Lett"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1002\/hep.30059","article-title":"Low-dose interleukin-2 for refractory autoimmune hepatitis","volume":"68","author":"Lim","year":"2018","journal-title":"Hepatology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1002\/hep.27998","article-title":"A novel humanized mouse model for autoimmune hepatitis and the association of gut microbiota with liver inflammation","volume":"62","author":"Yuksel","year":"2015","journal-title":"Hepatology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.3390\/ijms16011980","article-title":"Medullary thymic epithelial cells and central tolerance in autoimmune hepatitis development: novel perspective from a new mouse model","volume":"16","author":"Alexandropoulos","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B44","first-page":"99","article-title":"Experimental chronic active hepatitis in rabbits following immunization with human liver proteins","volume":"11","author":"Buschenfelde","year":"1972","journal-title":"Clin Exp Immunol"},{"key":"B45","first-page":"309","article-title":"Experimental autoimmune hepatitis in mice following immunization with syngeneic liver proteins","volume":"26","author":"Mihas","year":"1995","journal-title":"J Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/hep.1840110106","article-title":"Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity","volume":"11","author":"Lohse","year":"1990","journal-title":"Hepatology"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1002\/hep.29716","article-title":"CD36 deficiency attenuates immune-mediated hepatitis in mice by modulating the proapoptotic effects of CXC chemokine ligand 10","volume":"67","author":"Xu","year":"2018","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"9689","DOI":"10.1021\/acsnano.7b04630","article-title":"Immunomodulatory therapy of inflammatory liver disease using selectin-binding glycopolymers","volume":"11","author":"Bartneck","year":"2017","journal-title":"ACS Nano"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/hep.28112","article-title":"Hepatic stellate cells relay inflammation signaling from sinusoids to parenchyma in mouse models of immune-mediated hepatitis","volume":"63","author":"Fujita","year":"2016","journal-title":"Hepatology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1053\/gast.1996.v111.pm8690213","article-title":"Interferon gamma plays a critical role in T cell\u2013dependent liver injury in mice initiated by concanavalin A","volume":"111","author":"K\u00fcsters","year":"1996","journal-title":"Gastroenterology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3148","DOI":"10.4049\/jimmunol.1900124","article-title":"TNF-producing Th1 cells are selectively expanded in liver infiltrates of patients with autoimmune hepatitis","volume":"203","author":"Bovensiepen","year":"2019","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.2967\/jnumed.118.210328","article-title":"(18)F-FAC PET selectively images liver-infiltrating CD4 and CD8 T cells in a mouse model of autoimmune hepatitis","volume":"59","author":"Salas","year":"2018","journal-title":"J Nucl Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1479-5876-11-146","article-title":"Complementary serum proteomic analysis of autoimmune hepatitis in mice and patients","volume":"11","author":"Li","year":"2013","journal-title":"J Transl Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/cmi.2016.57","article-title":"CD24 aggravates acute liver injury in autoimmune hepatitis by promoting IFN-gamma production by CD4(+) T cells","volume":"15","author":"Zheng","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.freeradbiomed.2019.12.026","article-title":"Caveolin-1 dictates ferroptosis in the execution of acute immune-mediated hepatic damage by attenuating nitrogen stress","volume":"148","author":"Deng","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1172\/JCI113949","article-title":"Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1","volume":"83","author":"Manns","year":"1989","journal-title":"J Clin Invest"},{"key":"B57","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","article-title":"Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis","volume":"116","author":"Lapierre","year":"1999","journal-title":"Gastroenterology"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1002\/hep.20109","article-title":"A murine model of type 2 autoimmune hepatitis: xenoimmunization with human antigens","volume":"39","author":"Lapierre","year":"2004","journal-title":"Hepatology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1111\/j.1478-3231.2011.02600.x","article-title":"Different sites of xenoantigen delivery lead to a virally induced late-onset hepatitis in mice through molecular mimicry","volume":"31","author":"Pich\u00e9","year":"2011","journal-title":"Liver International"},{"key":"B60","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jaut.2005.11.001","article-title":"Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development","volume":"26","author":"Lapierre","year":"2006","journal-title":"J Autoimmun"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/hep.23536","article-title":"Forkhead box p3+ regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis","volume":"51","author":"Lapierre","year":"2010","journal-title":"Hepatology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1159\/000282068","article-title":"Cytochrome P450 2D6 as a model antigen","volume":"28","author":"Christen","year":"2010","journal-title":"Dig Dis"},{"key":"B63","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaut.2012.11.001","article-title":"Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis","volume":"42","author":"Ehser","year":"2013","journal-title":"J Autoimmun"},{"key":"B64","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jaut.2016.02.007","article-title":"Non-alcoholic fatty liver disease (NAFLD) potentiates autoimmune hepatitis in the CYP2D6 mouse model","volume":"69","author":"Muller","year":"2016","journal-title":"J Autoimmun"},{"key":"B65","first-page":"105","article-title":"Effect of neonatal thymectomy on experimental autoimmune hepatitis in mice","volume":"67","author":"Watanabe","year":"1987","journal-title":"Clin Exp Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"4889","DOI":"10.4049\/jimmunol.169.9.4889","article-title":"DNA vaccination breaks tolerance for a neo-self antigen in liver: a transgenic murine model of autoimmune hepatitis","volume":"169","author":"Djilali-Saiah","year":"2002","journal-title":"J Immunol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.clim.2005.08.010","article-title":"Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12","volume":"117","author":"Tamaki","year":"2005","journal-title":"Clin Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.4049\/jimmunol.1600228","article-title":"Transient expression of transgenic IL-12 in mouse liver triggers unremitting inflammation mimicking human autoimmune hepatitis","volume":"197","author":"Gil-Farina","year":"2016","journal-title":"J Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jhep.2006.08.022","article-title":"Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitis","volume":"46","author":"Warren","year":"2007","journal-title":"J Hepatol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/hep.21796","article-title":"Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis","volume":"46","author":"Derkow","year":"2007","journal-title":"Hepatology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1053\/j.gastro.2010.05.075","article-title":"Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis","volume":"139","author":"Zierden","year":"2010","journal-title":"Gastroenterology"},{"key":"B72","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/cei.12843","article-title":"The induction of autoimmune hepatitis in the human leucocyte antigen-DR4 non-obese diabetic mice autoimmune hepatitis mouse model","volume":"186","author":"Yuksel","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"e66604","DOI":"10.1371\/journal.pone.0066604","article-title":"Development of a spontaneous liver disease resembling autoimmune hepatitis in mice lacking tyro3, axl and mer receptor tyrosine kinases","volume":"8","author":"Qi","year":"2013","journal-title":"PLoS ONE."},{"key":"B74","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1172\/JCI65414","article-title":"Medullary thymic epithelial cell depletion leads to autoimmune hepatitis","volume":"123","author":"Bonito","year":"2013","journal-title":"J Clin Invest"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/hep.27639","article-title":"Autoimmune hepatitis in a murine autoimmune polyendocrine syndrome type 1 model is directed against multiple autoantigens","volume":"61","author":"Hardtke-Wolenski","year":"2015","journal-title":"Hepatology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1053\/j.gastro.2008.06.042","article-title":"Fatal autoimmune hepatitis induced by concurrent loss of naturally arising regulatory T cells and PD-1-mediated signaling","volume":"135","author":"Kido","year":"2008","journal-title":"Gastroenterology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1053\/j.gastro.2013.03.011","article-title":"Splenectomy prolongs the effects of corticosteroids in mouse models of autoimmune hepatitis","volume":"145","author":"Maruoka","year":"2013","journal-title":"Gastroenterology"},{"key":"B78","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hep.27087","article-title":"Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice","volume":"60","author":"Ikeda","year":"2014","journal-title":"Hepatology"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1182\/blood-2015-06-653667","article-title":"Umbilical cord blood-derived T regulatory cells to prevent GVHD. kinetics, toxicity profile, and clinical effect","volume":"127","author":"Brunstein","year":"2016","journal-title":"Blood"},{"key":"B80","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/art.40737","article-title":"Autoimmunity E centers of: adoptive Treg cell therapy in a patient with systemic lupus erythematosus","volume":"71","author":"Dall'Era","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/j.jaci.2018.10.015","article-title":"Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: the next frontier","volume":"142","author":"Esensten","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/hep.26023","article-title":"Adoptive transfer of ex vivo expanded regulatory T cells in an autoimmune hepatitis murine model restores peripheral tolerance","volume":"57","author":"Lapierre","year":"2013","journal-title":"Hepatology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cellimm.2018.03.003","article-title":"High fiber dietary and sodium butyrate attenuate experimental autoimmune hepatitis through regulation of immune regulatory cells and intestinal barrier","volume":"328","author":"Hu","year":"2018","journal-title":"Cell Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"e0143715","DOI":"10.1371\/journal.pone.0143715","article-title":"The role of regulatory CD4 T cells in maintaining tolerance in a mouse model of autoimmune hepatitis","volume":"10","author":"An Haack","year":"2015","journal-title":"PLoS ONE"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1139\/cjpp-2018-0467","article-title":"Inhibition of microRNA-155 attenuates concanavalin-A-induced autoimmune hepatitis by regulating Treg\/Th17 cell differentiation","volume":"96","author":"Xia","year":"2018","journal-title":"Can J Physiol Pharmacol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/hep.21498","article-title":"IL-10, regulatory T cells, and Kupffer cells mediate tolerance in concanavalin A-induced liver injury in mice","volume":"45","author":"Erhardt","year":"2007","journal-title":"Hepatology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.molimm.2013.11.001","article-title":"The Tim-3\/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis","volume":"58","author":"Ju","year":"2014","journal-title":"Mol Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1124\/mol.108.047035","article-title":"Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells","volume":"74","author":"Hegde","year":"2008","journal-title":"Mol Pharmacol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"3753081","DOI":"10.1155\/2018\/3753081","article-title":"The imbalance between Foxp3(+)Tregs and Th1\/Th17\/Th22 cells in patients with newly diagnosed autoimmune hepatitis","volume":"2018","author":"Liang","year":"2018","journal-title":"J Immunol Res"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3791\/59174","article-title":"Induction of drug-induced, autoimmune hepatitis in BALB\/c mice for the study of its pathogenic mechanisms","author":"Thomas","year":"2020","journal-title":"J Vis Exp."},{"key":"B91","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbrc.2019.02.147","article-title":"Adoptive transfer of regulatory T cells stimulated by Allogeneic Hepatic Stellate Cells mitigates liver injury in mice with concanavalin A-induced autoimmune hepatitis","volume":"512","author":"Huang","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"B92","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.3892\/mmr.2019.10750","article-title":"The JAK inhibitor tofacitinib ameliorates immunemediated liver injury in mice","volume":"20","author":"Wang","year":"2019","journal-title":"Mol Med Rep"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e0181107","DOI":"10.1371\/journal.pone.0181107","article-title":"Pediatric autoimmune hepatitis shows a disproportionate decline of regulatory T cells in the liver and of IL-2 in the blood of patients undergoing therapy","volume":"12","author":"Diestelhorst","year":"2017","journal-title":"PLoS ONE"},{"key":"B94","doi-asserted-by":"publisher","first-page":"682","DOI":"10.5604\/16652681.1212319","article-title":"Assessment of intrahepatic regulatory T cells in children with autoimmune hepatitis","volume":"15","author":"Behairy","year":"2016","journal-title":"Ann Hepatol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/hep.23792","article-title":"A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis","volume":"52","author":"Ferri","year":"2010","journal-title":"Hepatology"},{"key":"B96","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/j.1872-034X.2008.00349.x","article-title":"Deficiency of forkhead box P3 and cytotoxic T-lymphocyte-associated antigen-4 gene expressions and impaired suppressor function of CD4(+)CD25(+) T cells in patients with autoimmune hepatitis","volume":"38","author":"Okumura","year":"2008","journal-title":"Hepatol Res"},{"key":"B97","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","article-title":"Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis","volume":"25","author":"Longhi","year":"2005","journal-title":"J Autoimmun"},{"key":"B98","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J Hepatol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/hep.25682","article-title":"The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9\/tim-3 pathway","volume":"56","author":"Liberal","year":"2012","journal-title":"Hepatology"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1002\/hep.26583","article-title":"Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis","volume":"59","author":"Grant","year":"2014","journal-title":"Hepatology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jhepr.2019.08.001","article-title":"Liver homing of clinical grade Tregs after therapeutic infusion in patients with autoimmune hepatitis","volume":"1","author":"Oo","year":"2019","journal-title":"JHEP Reports"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/hep.30031","article-title":"The impact of autoimmune hepatitis and its treatment on health utility","volume":"68","author":"Wong","year":"2018","journal-title":"Hepatology"},{"key":"B103","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1053\/j.gastro.2011.02.065","article-title":"Long-term outcomes of patients with autoimmune hepatitis managed at a nontransplant center","volume":"140","author":"Hoeroldt","year":"2011","journal-title":"Gastroenterology"},{"key":"B105","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jhep.2014.10.018","article-title":"Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis","volume":"62","author":"Hartl","year":"2015","journal-title":"J Hepatol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.jhep.2014.05.034","article-title":"Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies","volume":"61","author":"Taubert","year":"2014","journal-title":"J Hepatol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.clim.2017.12.004","article-title":"Altered natural killer cell cytokine profile in type 2 autoimmune hepatitis","volume":"188","author":"Mele","year":"2018","journal-title":"Clin Immunol."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1053\/j.gastro.2012.02.041","article-title":"Inhibition of interleukin-17 promotes differentiation of CD25(-) cells into stable T regulatory cells in patients with autoimmune hepatitis","volume":"142","author":"Longhi","year":"2012","journal-title":"Gastroenterology"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2337\/dc12-0038","article-title":"Administration of CD4+CD25highCD127- regulatory T cells preserves \u03b2-cell function in type 1 diabetes in children","volume":"35","author":"Marek-Trzonkowska","year":"2012","journal-title":"Diabetes Care"},{"key":"B110","doi-asserted-by":"publisher","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med"},{"key":"B111","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/hep.22071","article-title":"Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis","volume":"47","author":"Longhi","year":"2008","journal-title":"Hepatology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jaut.2014.02.001","article-title":"Retinoic acid stabilizes antigen-specific regulatory T-cell function in autoimmune hepatitis type 2","volume":"53","author":"Holder","year":"2014","journal-title":"J Autoimmun"},{"key":"B113","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/hep.24039","article-title":"Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis","volume":"53","author":"Longhi","year":"2011","journal-title":"Hepatology"},{"key":"B114","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-pathol-020117-043534","article-title":"Cellular and molecular mechanisms of autoimmune hepatitis","volume":"13","author":"Webb","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1111\/jcmm.14997","article-title":"Dysregulated TFR and TFH cells correlate with B-cell differentiation and antibody production in autoimmune hepatitis","volume":"24","author":"Liang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B116","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s10787-019-00599-0","article-title":"Total flavonoids from Tetrastigma hemsleyanum ameliorates inflammatory stress in concanavalin A-induced autoimmune hepatitis mice by regulating Treg\/Th17 immune homeostasis","volume":"27","author":"Ji","year":"2019","journal-title":"Inflammopharmacology"},{"key":"B117","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4049\/jimmunol.1600418","article-title":"A proinflammatory role of type 2 innate lymphoid cells in murine immune-mediated hepatitis","volume":"198","author":"Neumann","year":"2017","journal-title":"J Immunol"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1002\/hep.23191","article-title":"Priming of CD4+ T cells by liver sinusoidal endothelial cells induces CD25low forkhead box protein 3- regulatory T cells suppressing autoimmune hepatitis","volume":"50","author":"Kruse","year":"2009","journal-title":"Hepatology"},{"key":"B119","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jaut.2015.01.011","article-title":"Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis","volume":"59","author":"Wang","year":"2015","journal-title":"J Autoimmun"},{"key":"B120","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1365-2249.2009.03898.x","article-title":"Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population","volume":"156","author":"Rong","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00005-018-0515-9","article-title":"Deviations in peripheral blood cell populations are associated with the stage of primary biliary cholangitis and presence of itching","volume":"66","author":"Cichoz-Lach","year":"2018","journal-title":"Arch Immunol Ther Exp"},{"key":"B122","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jaut.2006.04.005","article-title":"IL-2 receptor alpha deficiency and features of primary biliary cirrhosis","volume":"27","author":"Aoki","year":"2006","journal-title":"J Autoimmun"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/hep.21385","article-title":"IL-2 receptor alpha(-\/-) mice and the development of primary biliary cirrhosis","volume":"44","author":"Wakabayashi","year":"2006","journal-title":"Hepatology"},{"key":"B124","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/hep.22591","article-title":"Differential mechanisms in the pathogenesis of autoimmune cholangitis versus inflammatory bowel disease in interleukin-2Ralpha(-\/-) mice","volume":"49","author":"Hsu","year":"2009","journal-title":"Hepatology"},{"key":"B125","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/cei.12415","article-title":"Successful immunotherapy of autoimmune cholangitis by adoptive transfer of forkhead box protein 3(+) regulatory T cells","volume":"178","author":"Tanaka","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1002\/hep.21123","article-title":"Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis","volume":"43","author":"Lan","year":"2006","journal-title":"Hepatology"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.jhep.2013.12.027","article-title":"Reduced FOXP3(+) regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms","volume":"60","author":"Sebode","year":"2014","journal-title":"J Hepatol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.jhep.2016.12.001","article-title":"Dysfunction of hepatic regulatory T cells in experimental sclerosing cholangitis is related to IL-12 signaling","volume":"66","author":"Schwinge","year":"2017","journal-title":"J Hepatol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"Treg cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"e465","DOI":"10.1212\/NXI.0000000000000465","article-title":"Expanded autologous regulatory T-lymphocyte infusions in ALS. A phase I, first-in-human study","volume":"5","author":"Thonhoff","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B131","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1136\/annrheumdis-2019-215396","article-title":"Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial","volume":"79","author":"He","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B132","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/annrheumdis-2018-214229","article-title":"Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial","volume":"78","author":"Rosenzwajg","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B133","doi-asserted-by":"publisher","first-page":"e99306","DOI":"10.1172\/jci.insight.99306","article-title":"The DILfrequency study is an adaptive trial to identify optimal IL-2 dosing in patients with type 1 diabetes","volume":"3","author":"Seelig","year":"2018","journal-title":"JCI Insight"},{"key":"B134","doi-asserted-by":"publisher","first-page":"e1002139","DOI":"10.1371\/journal.pmed.1002139","article-title":"Regulatory T cell responses in participants with type 1 diabetes after a single dose of interleukin-2: a non-randomised, open label, adaptive dose-finding trial","volume":"13","author":"Todd","year":"2016","journal-title":"PLoS Med"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1002\/hep.27983","article-title":"Prediction of short- and long-term outcome in patients with autoimmune hepatitis","volume":"62","author":"Kirstein","year":"2015","journal-title":"Hepatology"},{"key":"B136","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.jhep.2013.10.020","article-title":"Autoimmune hepatitis in Denmark: incidence, prevalence, prognosis, and causes of death. A nationwide registry-based cohort study","volume":"60","author":"Gronbaek","year":"2014","journal-title":"J Hepatol"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1002\/hep.26454","article-title":"Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history","volume":"58","author":"Deneau","year":"2013","journal-title":"Hepatology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.575572\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,7]],"date-time":"2020-10-07T07:02:41Z","timestamp":1602054161000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.575572\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,7]]},"references-count":137,"alternative-id":["10.3389\/fimmu.2020.575572"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.575572","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,7]]},"article-number":"575572"}}